Ashton Tweed Connection Vol. 3 No. 4

Featuring CEO Interview with Kenneth L. Londoner, Executive Chairman, BioSig Technologies, Inc.

Volume 3, Number 4

Whether you are or you require executive or management talent — interim, permanent, or interim to hire — Ashton Tweed can meet your specialized retained search and executive search needs.

CEO Leadership Series: Kenneth L. Londoner, Executive Chairman, BioSig Technologies, Inc.

With an investment and business development background, Kenneth Londoner’s career is proof no set or predictable path to running a biomedical company exists. Londoner considers himself to be an entrepreneur first, one who achieved success inside and outside the biomedical industry long before he co-founded BioSig Technologies, Inc.

6 Tips on Making the Move From a Large Company to a Small One

In 2015, the FDA awarded over $19 million in research grants to boost the development of products to treat rare diseases. Recently, there have been many similar pushes to provide treatments for patients with little or no treatment options. However, working with orphan diseases presents a new set of challenges in the life science industries…

Rare/Orphan Disease Challenges And How Interim Can Help

Many executives in the life sciences kick off their careers in large companies and then, after gaining substantial experience, leave for a small company or start-up. Having helped several executives make this move during my career at Ashton Tweed and having done that myself, I know how exciting this transition can be. However, there are some major changes…


	Don’t Miss OUR Life Sciences Weekly Digest! Go beyond our newsletter… Subscribe Today for Ashton Tweed’s Weekly Digest Emails that cover hiring, firing, and retiring news in the Life sciences. Click below to enhance your subscription:

The Highest Paying Life Sciences Jobs in 2015

The Scientist’s 2015 Life Sciences Salary Report collected data on the top-paying fields in life sciences worldwide. Their survey broke down the highest paying jobs in academia, industry and other categories. See which titles and salaries made the list here…

Another Genentech? These are the most likely companies

San Francisco Business Times took a look at the Bay Area’s life sciences industry and found that Genentech is still the gold standard. However, these nine companies do stand out as having the potential to become the next Genentech. See which companies made the list here…

UPS teams with Zipline, Gavi to deliver medical supplies using drones

UPS teams up with California robotics company Zipline and Gavi, the Vaccine Alliance, to test the use of drones to deliver medical supplies. Later this year, they will deliver blood to facilities in western Rwanda, a mountainous region where overland transport is difficult. The Rwandan government is looking to cut delivery timelines…

Yale creates Hugo to make it easier for patients to open EHRs up to researchers

Yale creates Hugo to make it easier for patients to open EHRs to researchers

Yale School of Medicine and Yale New Haven Health System have unveiled a platform named Hugo, designed to make it easier for patients to access their electronic health records (EHRs) and share them with researchers. While the healthcare system has access to this information, it’s difficult for an individual to access all of their…

FACT SHEET: Announcing the National Microbiome Initiative

The White House Office of Science and Technology Policy, in collaboration with Federal agencies and private-sector stakeholders, announced a new National Microbiome Initiative (NMI) to foster the integrated study of microbiomes across different ecosystems. Microbiomes maintain the healthy function of all ecosystems and issues can influence human health, climate change, food security, and other…

Opioid Prescriptions Drop for First Time in Two Decades

After years of relentless growth, the number of opioid prescriptions in the U.S. is finally falling, the first sustained drop since 1996. IMS Health found a 12% decline in opioid prescriptions nationally since a peak in 2012. Symphony Health Solutions reported a drop of about 18%…

Reprocessed Medical Device Market Size to Triple by 2022

According to a study by Grand View Research, Inc., the worldwide reprocessed medical device market is set to triple to $5 billion by 2022 as healthcare facilities look to cut costs and reduce waste. The study finds that the global market is expected to grow at an over 20% compound…